Modified fibrin hydrogels stimulate angiogenesis in vivo

Potential application to increase perfusion of ischemic tissues

H. Hall, J. A. Hubbell

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The lack of angiogenesis in ischemic tissues is a major health problem and many studies aim to explore strategies to locally increase blood perfusion. Our approach is to use covalently modified fibrin-based hydrogels as a matrix that induces endothelial cell survival in vitro and angiogenesis in vivo. Fibrin hydrogels were covalently modified by L1Ig6, a specific receptor for cell survival integrin αvβ3 that is expressed on angiogenic endothelial cells. In addition, L1Ig6-modified matrices were filled with growth factors VEGF-A165 or bFGF. These hydrogels were applied on growing shell-free chicken chorioallantoic membranes (CAMs) and the developing vasculature was found to be increased by ∼50%. Moreover, the increase in αv-integrin levels in the CAMs underlying the hydrogel implants were investigated and found to be increased by ∼40% and ∼100%, respectively, after CAM stimulation with L1Ig6 alone or in combination with growth factors VEGF-A165 and bFGF. Therefore, modified fibrin hydrogels provide an interesting way to design an implant that can be introduced at the site of ischemia, and provides a scaffold and release system for growth factors that induce specific tissue responses.

Original languageEnglish
Pages (from-to)768-774
Number of pages7
JournalMaterialwissenschaft und Werkstofftechnik
Volume36
Issue number12
DOIs
StatePublished - Dec 1 2005
Externally publishedYes

Fingerprint

fibrin
angiogenesis
Hydrogels
Fibrin
Chorioallantoic Membrane
Perfusion
Tissue
membranes
Intercellular Signaling Peptides and Proteins
Endothelial cells
Membranes
Integrins
Vascular Endothelial Growth Factor A
ischemia
Cell Survival
chickens
Endothelial Cells
matrices
stimulation
health

Keywords

  • αVβ3 integrin
  • Angiogenesis
  • CAM assay
  • Endothelial cells
  • HUVECs
  • L1ig6
  • NFκB

ASJC Scopus subject areas

  • Materials Science(all)
  • Biotechnology
  • Biochemistry

Cite this

Modified fibrin hydrogels stimulate angiogenesis in vivo : Potential application to increase perfusion of ischemic tissues. / Hall, H.; Hubbell, J. A.

In: Materialwissenschaft und Werkstofftechnik, Vol. 36, No. 12, 01.12.2005, p. 768-774.

Research output: Contribution to journalArticle

@article{fd572c3d56b24b98898f94e51be5f1a0,
title = "Modified fibrin hydrogels stimulate angiogenesis in vivo: Potential application to increase perfusion of ischemic tissues",
abstract = "The lack of angiogenesis in ischemic tissues is a major health problem and many studies aim to explore strategies to locally increase blood perfusion. Our approach is to use covalently modified fibrin-based hydrogels as a matrix that induces endothelial cell survival in vitro and angiogenesis in vivo. Fibrin hydrogels were covalently modified by L1Ig6, a specific receptor for cell survival integrin αvβ3 that is expressed on angiogenic endothelial cells. In addition, L1Ig6-modified matrices were filled with growth factors VEGF-A165 or bFGF. These hydrogels were applied on growing shell-free chicken chorioallantoic membranes (CAMs) and the developing vasculature was found to be increased by ∼50{\%}. Moreover, the increase in αv-integrin levels in the CAMs underlying the hydrogel implants were investigated and found to be increased by ∼40{\%} and ∼100{\%}, respectively, after CAM stimulation with L1Ig6 alone or in combination with growth factors VEGF-A165 and bFGF. Therefore, modified fibrin hydrogels provide an interesting way to design an implant that can be introduced at the site of ischemia, and provides a scaffold and release system for growth factors that induce specific tissue responses.",
keywords = "αVβ3 integrin, Angiogenesis, CAM assay, Endothelial cells, HUVECs, L1ig6, NFκB",
author = "H. Hall and Hubbell, {J. A.}",
year = "2005",
month = "12",
day = "1",
doi = "10.1002/mawe.200500966",
language = "English",
volume = "36",
pages = "768--774",
journal = "Materialwissenschaft und Werkstofftechnik",
issn = "0933-5137",
publisher = "Wiley-VCH Verlag",
number = "12",

}

TY - JOUR

T1 - Modified fibrin hydrogels stimulate angiogenesis in vivo

T2 - Potential application to increase perfusion of ischemic tissues

AU - Hall, H.

AU - Hubbell, J. A.

PY - 2005/12/1

Y1 - 2005/12/1

N2 - The lack of angiogenesis in ischemic tissues is a major health problem and many studies aim to explore strategies to locally increase blood perfusion. Our approach is to use covalently modified fibrin-based hydrogels as a matrix that induces endothelial cell survival in vitro and angiogenesis in vivo. Fibrin hydrogels were covalently modified by L1Ig6, a specific receptor for cell survival integrin αvβ3 that is expressed on angiogenic endothelial cells. In addition, L1Ig6-modified matrices were filled with growth factors VEGF-A165 or bFGF. These hydrogels were applied on growing shell-free chicken chorioallantoic membranes (CAMs) and the developing vasculature was found to be increased by ∼50%. Moreover, the increase in αv-integrin levels in the CAMs underlying the hydrogel implants were investigated and found to be increased by ∼40% and ∼100%, respectively, after CAM stimulation with L1Ig6 alone or in combination with growth factors VEGF-A165 and bFGF. Therefore, modified fibrin hydrogels provide an interesting way to design an implant that can be introduced at the site of ischemia, and provides a scaffold and release system for growth factors that induce specific tissue responses.

AB - The lack of angiogenesis in ischemic tissues is a major health problem and many studies aim to explore strategies to locally increase blood perfusion. Our approach is to use covalently modified fibrin-based hydrogels as a matrix that induces endothelial cell survival in vitro and angiogenesis in vivo. Fibrin hydrogels were covalently modified by L1Ig6, a specific receptor for cell survival integrin αvβ3 that is expressed on angiogenic endothelial cells. In addition, L1Ig6-modified matrices were filled with growth factors VEGF-A165 or bFGF. These hydrogels were applied on growing shell-free chicken chorioallantoic membranes (CAMs) and the developing vasculature was found to be increased by ∼50%. Moreover, the increase in αv-integrin levels in the CAMs underlying the hydrogel implants were investigated and found to be increased by ∼40% and ∼100%, respectively, after CAM stimulation with L1Ig6 alone or in combination with growth factors VEGF-A165 and bFGF. Therefore, modified fibrin hydrogels provide an interesting way to design an implant that can be introduced at the site of ischemia, and provides a scaffold and release system for growth factors that induce specific tissue responses.

KW - αVβ3 integrin

KW - Angiogenesis

KW - CAM assay

KW - Endothelial cells

KW - HUVECs

KW - L1ig6

KW - NFκB

UR - http://www.scopus.com/inward/record.url?scp=30344476098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30344476098&partnerID=8YFLogxK

U2 - 10.1002/mawe.200500966

DO - 10.1002/mawe.200500966

M3 - Article

VL - 36

SP - 768

EP - 774

JO - Materialwissenschaft und Werkstofftechnik

JF - Materialwissenschaft und Werkstofftechnik

SN - 0933-5137

IS - 12

ER -